ArticleCureus2025
A Case Report Exploring Early-Onset Alzheimer's Disease With No Known Family History.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report conveys a rare presentation of early-onset Alzheimer's disease (EOAD) in a 58-year-old female with no family history of dementia. The patient demonstrates progressive cognitive decline with features of memory loss and associated severe language impairment, subsequently leading to a delay in the definite diagnosis. A systematic literature review using PubMed and Google Scholar was undertaken to explore the features of EOAD and how it differs from late-onset Alzheimer's disease (AD), focusing on risk factors, clinical presentation, investigation, and management. Although this patient was not known to have a family history of AD, evidence suggestive of EOAD could be observed within a series of neuroimaging and diagnostic tests such as magnetic resonance imaging scans, cerebrospinal fluid analysis, and blood tests. Management of EOAD involves a combination of pharmacological and non-pharmacological interventions using a biopsychosocial approach. Overall, the case highlights challenges in recognition of EOAD in its early stages of presentation for patients with no family predisposition, whilst emphasizing the importance of early detection and management to help improve patient outcomes. It also focuses attention on the significant impact a condition such as EOAD can have on the family members involved. Further research would be required to potentially redefine diagnostic criteria and treatment strategies for conditions of such rarity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.